Skip to main content

HOPA Abstracts

A Pooled Safety Analysis of Loncastuximab Tesirine in Relapsed or Refractory DLBCL in the LOTIS Clinical Trial Program: Incidence, Onset, and Management of Myelosuppression
Abstract #CR01
Read More
Evaluation of Empiric Double Coverage with Tobramycin for Adult Patients with Febrile Neutropenia
Abstract #CR02
Read More
Treatment Patterns, Real-World Outcomes, and Resource Use in Patients with Non–MSI-High or Mismatch Repair Proficient Advanced Endometrial Cancer
Abstract #CR03
Read More
Development and Implementation of a Pharmacist-Led Virtual Clinic Improve the Management of Patients with Metastatic Breast Cancer Receiving CDK4/6 Inhibitors
Abstract #CR04
Read More
Impact of a Remote Oncology Clinical Pharmacist Program in 4 Community Oncology Practices
Abstract #CR05
Read More
Impact of PGY2 Oncology Pharmacy Residents’ Learning Experiences During the COVID-19 Pandemic
Abstract #CR06
Read More
Integrated Health-System Specialty Pharmacy Support in Reducing Financial Toxicity of Oral Oncolytic Therapy
Abstract #CR07
Read More
Perceptions of PGY2 Oncology Programs on Financial Toxicity Education and Preparedness
Abstract #CR08
Read More
Pharmacist-Led Oral Chemotherapy Monitoring Pilot Study and Assessment of Patient-Reported Outcomes and Adherence
Abstract #CR09
Read More
The Impact of a Comprehensive Immunotherapy Continuing Education Curriculum on Pharmacists’ Knowledge, Competence, and Confidence
Abstract #CR10
Read More
Page 9 of 12
Results 81 - 90 of 119